Information
Teva Pharmaceuticals USA Recalls Carton label: Testosterone Gel 1%
This is a Class III recall. This product is unlikely to cause adverse health reactions but violates FDA regulations.
Source: FDA
InfoRecall #D-0198-2026Drug / Pharmaceutical
Teva Pharmaceuticals USA Recalls Carton label: Testosterone Gel 1%
Teva Pharmaceuticals USA, Inc · Class III — Regulatory
Product Description
Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3216-30. Packet label: Testosterone Gel 1%, contains 2.5 grams, For topical use only, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054,NDC: 0591-3216-17.
Reason for Recall
Defective Container - A defect in the side-seal which allows leakage of product.
FDA Classification
Class III — Regulatory
A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Distribution
U.S. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Teva Pharmaceuticals USA, Inc initiated a Class III recall of a pharmaceutical product on November 7, 2025 affecting 15,944 cartons. Defective Container - A defect in the side-seal which allows leakage of product. Class III recalls involve products that are unlikely to cause adverse health reactions but violate FDA regulations. The product was distributed in U.S. Nationwide. Consumers may continue monitoring FDA updates regarding this recall.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects and Teva Pharmaceuticals USA recalls.